Diabetes Mellitus and Cerebral Vascular Accident;Diabetes Mellitus a Cévní Onemocnění Mozku

Vnitrni Lekarstvi

Volumn 49, Issue 12, 2003, Pages 916-920

  Souček, Miroslav ^a  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

Author keywords

Antithrombotic therapy; Cerebral vascular accident; Diabetes mellitus; Dyslipidaemia; Hypertension

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; SIMVASTATIN; TICLOPIDINE;

ARTICLE; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; CZECH REPUBLIC; DEVELOPED COUNTRY; DIABETES MELLITUS; DYSLIPIDEMIA; EARLY DIAGNOSIS; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INCIDENCE; METABOLIC SYNDROME X; MORTALITY; PATHOGENESIS; PROGNOSIS; RISK FACTOR; WESTERN EUROPE;

CEREBROVASCULAR ACCIDENT; DIABETIC ANGIOPATHIES; HUMANS;

EID: 1642471888     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Perušičová, J.: Trendy soudobé diabetologie. Galén, Praha 2002, 146 s.
2. Bauer, J., Fiksa, J., Horáčková, I. et al.: Stroke unit - význam specializované péče o nemocné s CMP. Čs. Neurol. Neurochir., 2000; Suppl. 2: 10
3. Weber, P.: Diabetes mellitus in advanced age - a diabetologist's view. Euro. J. Ger., 4, 2002; 4: 167-172
4. Perušičová, J.: Diabetické makroangiopatie a mikroangiopatie. Galén, Praha 2003, 262 s.
5. Svačina, Š.: Metabolický syndrom. Triton, Praha, 2002, 185 s.
6. Bartoš, V.: Diabetes a iktus. DMEV 3, 2000; 227-232
7. Vinik, A., Flemmer, M.: Diabetes and macrovascular disease. Journal of Diabetes and Its Complications 16, 2002; 235-245
8. Kudláčková Z., Hronek, M.: Hladina glykémie - ukazatel závažnosti ischemického poškození mozku. DMEV 4, 2001; 287-298
9. Chlumský, J., Charvát, J.: Echokardiografie a monografie karotid u diabetiků s cévní mozkovou příhodou. Vnitř. Lék. 46, 2000; 848-850
10. Chlumský, J.: Diagnostika a léčba cévních mozkových příhod. Prakt. Lék., 2000; 6: 314-316
11. Gaba, M. K., Gaba, L. K.: Cardiovascular disease in patients with diabetes: clinical considerations. Journal of the Association of the Academy of Minor Physics. 1999; 10: 15-22
12. Stern, M. P.: The effect of glycemic control on the incidence of macrovascular complications of Type 2 diabetes. Archives of Family Medicine, 1998; 7: 155-162
13. Bell, D. S. H.: Stroke in the diabetic patients. Diabetes Care, 17: 1994; 213-219
14. Wilson, P. W.: Diabetes mellitus and coronary heart disease. American Journal of Kidney Diseases, 32, 1998; S89-S100
15. Souček, M.: Hypertenze a mozkové cévní příhody. Vnitř. Lék., 12, 2001; 47: 868-874
16. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). Lancet, 352, 1998; 837-853
17. PROGRESS Colaborative Group. Randomised trial of perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet, 2001; 358: 1033-1041
18. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. New England Journal of Medicine, 342, 2000; 145-153
19. Sacks, F. M., Pfeffer, M. A., Moyle, L. A. et al.: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. New England Journal of Medicine, 335, 1996; 1001-1009
20. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet, 344, 1994; 1383-1389
21. American Diabetes Association. Aspirin therapy in diabetes (2001 position statement). Diabetes Care, 24 (Suppl. 1), 2001; S62-S63
22. Steering Committee of the Physicians Health Study Research Group. Final report on the aspirin component of the ongoing Physicians Health Study. New England Journal of Medicine, 321, 1989; 129-135
23. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet, 348, 1996; 1329-1339
24. Diener, H. C., Cunha, L., Forbes, C. et al.: European Stroke Prevention Study: Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. Journal of Neurological Science, 143, 1996; 1-13